Sage Therapeutics, INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
Sage Therapeutics will hold its annual stockholder meeting on June 11, 2025, featuring proposals including the election of directors, ratification of the company's accounting firm, executive compensation approval, and an amendment to the Employee Stock Purchase Plan.
Sage Therapeutics is holding its 2025 Annual Meeting of Stockholders to elect directors, ratify the appointment of auditors, approve executive compensation, and amend the Employee Stock Purchase Plan.
Sage Therapeutics announces its annual stockholder meeting to be held on June 10, 2024, with key voting items including the election of directors and ratification of the company's accounting firm.
Sage Therapeutics is holding its 2024 Annual Meeting of Stockholders virtually on June 10, 2024, to vote on key proposals, including the election of directors and approval of the 2024 Equity Incentive Plan.